المؤلفون: Irina A. Belyaeva, Elena P. Bombardirova, Elena O. Kurnatovskaya, И. А. Беляева, Е. П. Бомбардирова, Е. О. Курнатовская

المصدر: Current Pediatrics; Том 22, № 6 (2023); 498-505 ; Вопросы современной педиатрии; Том 22, № 6 (2023); 498-505 ; 1682-5535 ; 1682-5527

مصطلحات موضوعية: фототерапия, breastfeeding, neonatal hyperbilirubinemia, infants, phototherapy, грудное вскармливание, гипербилирубинемия новорожденных, младенцы

وصف الملف: application/pdf

Relation: https://vsp.spr-journal.ru/jour/article/view/3351/1346; Шабалов Н.П., Софронова Л.Н. Неонатология: в 2 т.: учебное пособие. — 7-е изд., перераб. и доп. — М.: ГЭОТАР-Медиа; 2020. — 720 с.; Newman AJ, Gross S. Hyperbilirubinemia in Breast-Fed Infants. Pediatrics. 1963;32(6):995-1001. doi: https://doi.org/10.1542/peds.32.6.995; Schneider AP 2nd. Breast milk jaundice in the newborn. A real entity. JAMA. 1986;255(23):3270-3274. doi: https://doi.org/10.1001/jama.1986.03370230076034; Неонатология: клинические рекомендации / под ред. Н.Н. Володина, Д.Н. Дегтярева, Д.С. Крючко. — М.: ГЭОТАР-Медиа; 2019. — 320 с.; Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3): e2022058859. doi: https://doi.org/10.1542/peds.2022-058859; Preer GL, Philipp BL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F461- F466. doi: https://doi.org/10.1136/adc.2010.184416; Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article. Iran J Public Health. 2016; 45(5):558-568.; Bratton S, Cantu RM, Stern M. Breast Milk Jaundice. 2023 Jan 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.; Ketsuwan S, Baiya N, Maelhacharoenporn K, Puapornpong P. The Association of Breastfeeding Practices with Neonatal Jaundice. J Med Assoc Thai. 2017;100(3):255-261.; Noel-Weiss J, Courant G, Woodend AK. Physiological weight loss in the breastfed neonate: a systematic review. Open Med. 2008;2(4):e99-e110.; Huang H, Huang J, Huang W, et al. Breast milk jaundice affects breastfeeding: From the perspective of intestinal flora and SCFAs-GPR41/43. Front Nutr. 2023;10:1121213. doi: https://doi.org/10.3389/fnut.2023.1121213; Prameela KK. Breastfeeding during breast milk jaundice — a pathophysiological perspective. Med J Malaysia. 2019;74(6):527-533.; Levitt DG, Levitt MD. Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease. Clin Exp Gastroenterol. 2014;7:307-328. doi: https://doi.org/10.2147/CEG.S64283; Flaherman VJ, Maisels MJ. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017. Breastfeed Med. 2017;12(5): 250-257. doi: https://doi.org/10.1089/bfm.2017.29042.vjf; Deshpande PG, Aslam M. Breast Milk Jaundice. In: Medscape. Updated: Nov 18, 2021. Available online: https://emedicine.medscape.com/article/973629-overview. Accessed on November 22, 2023.; Maisels MJ, Clune S, Coleman K, et al. The natural history of jaundice in predominantly breastfed infants. Pediatrics. 2014; 134(2):e340-e345. doi: https://doi.org/10.1542/peds.2013-4299; Bentz MG, Carmona N, Bhagwat MM, et al. Beyond “Asian”: Specific East and Southeast Asian Races or Ethnicities Associated With Jaundice Readmission. Hosp Pediatr. 2018;8(5):269-273. doi: https://doi.org/10.1542/hpeds.2017-0234; Gao C, Guo Y, Huang M, et al. Breast Milk Constituents and the Development of Breast Milk Jaundice in Neonates: A Systematic Review. Nutrients. 2023;15(10):2261. doi: https://doi.org/10.3390/nu15102261; Arias IM, Gartner LM, Seifter S, Furman M. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steroid, pregnane-3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J Clin Invest. 1964; 43(11):2037-2047. doi: https://doi.org/10.1172/jci105078; Guo Q, Cui M, Liu X, et al. Effect of Epidermal Growth Factor in Human Milk and Maternal Diet on Late-Onset Breast Milk Jaundice: A Case-Control Study in Beijing. Nutrients. 2022;14(21):4587. doi: https://doi.org/10.3390/nu14214587; Demirkol M, Bohles H. Breast milk taurine and its possible influence on the development of breast milk induced jaundice of the neonate — a hypothesis. Adv Exp Med Biol. 1994;359:405-410. doi: https://doi.org/10.1007/978-1-4899-1471-2_42; Amato M, Howald H, von Muralt G. Fat Content of Human Milk and Breast Milk Jaundice. Acta Paediatr Int J Paediatr. 1985;74(5):805-806. doi: https://doi.org/10.1111/j.1651-2227.1985.tb10039.x; Poland RL, Schultz GE, Garg G. High milk lipase activity associated with breast milk jaundice. Pediatr Res. 1980;14:1328-1331. doi: https://doi.org/10.1203/00006450-198012000-00011; Forsyth JS, Donnet L, Ross PE. A study of the relationship between bile salts, bile salt-stimulated lipase, and free fatty acids in breast milk: Normal infants and those with breast milk jaundice. J Pediatr Gastroenterol Nutr. 1990;11(2):205-210. doi: https://doi.org/10.1097/00005176-199008000-00009; Shibuya A, Itoh T, Tukey RH, Fujiwara R. Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia. Sci Rep. 2013;3:2903. doi: https://doi.org/10.1038/srep02903; Foliot A, Ploussard JP, Housset E, Christoforov. Breast milk jaundice: In vitro inhibition of rat liver bilirubin-uridine diphosphate glucuronyltransferase activity and Z protein-bromosulfophthalein binding by human breast milk. Pediatr Res. 1976;10(6):594-598. doi: https://doi.org/10.1203/00006450-197606000-00007; Gao C, Miller J, Middleton PF, et al. Changes to breast milk fatty acid composition during storage, handling and processing: A systematic review. Prostaglandins Leukot Essent Fatty Acids. 2019;146:1-10. doi: https://doi.org/10.1016/j.plefa.2019.04.008; Manganaro R, Marseglia L, Mami C, et al. Serum alphafetoprotein (AFP) levels in breastfed infants with prolonged indirect hyperbilirubinemia. Early Hum Dev. 2008;84:487-490. doi: https://doi.org/10.1016/j.earlhumdev.2008.01.005; Apaydin K, Ermis B, Arasli M, et al. Cytokines in human milk and late-onset breast milk jaundice. Pediatr Int. 2012;54(6):801-805. doi: https://doi.org/10.1111/j.1442-200X.2012.03680.x; Kumral A, Ozkan H, Duman N, et al. Breast milk jaundice correlates with high levels of epidermal growth factor. Pediatr Res. 2009;66(2):218-221. doi: https://doi.org/10.1203/PDR.0b013e3181ac4a30; Li Y, Shen N, Li J, et al. Changes in intestinal Flora and Metabolites in neonates with breast Milk jaundice. Front Pediatr. 2020;8:177. doi: https://doi.org/10.3389/fped.2020.00177; McCarville JL, Chen GY, Cuevas VD, et al. Microbiota metabolites in health and disease. Annu Rev Immunol. 2020;38:147-170. doi: https://doi.org/10.1146/annurev-immunol-071219-125715; Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6): 1174-1182. doi: https://doi.org/10.1136/gutjnl-2020-323071; Gonçalves P, Araújo JR, Di Santo JP. A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(3):558-572. doi: https://doi.org/10.1093/ibd/izx029; Kayama H, Okumura R, Takeda K. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol. 2020;38:23-48. doi: https://doi.org/10.1146/annurev-immunol-070119-115104; Hansen TWR, Wong RJ, Stevenson DK. Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn. Physiol Rev. 2020;100(3):1291-346. doi: https://doi.org/10.1152/physrev.00004.2019; Chen K, Yuan T. The role of microbiota in neonatal hyperbilirubinemia. Am J Transl Res. 2020;12:7459-7474.; Novák P Jackson AO, Zhao GJ, Yin K. Bilirubin in metabolic syndrome and associated inflammatory diseases: new perspectives. Life Sci. 2020;257:118032. doi: https://doi.org/10.1016/j.lfs.2020.118032; Ma J, Li Z, Zhang W, et al. Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants. Sci Rep. 2020;10:15792. doi: https://doi.org/10.1038/s41598-020-72635-x; Guo Q, Liu X, Cui M, et al. Characteristics of intestinal microbiota in infants with late-onset breast milk jaundice. Front Nutr. 2023;10: 1119768. doi: https://doi.org/10.3389/fnut.2023.1119768; Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581-616. doi: https://doi.org/10.1146/annurev.pharmtox.40.1.581.; Maisels MJ, Kring E. Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med. 2002;156(7): 669-672. doi: https://doi.org/10.1001/archpedi.156.7.669; Fujiwara R, Maruo Y, Chen S, Tukey RH. Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. Toxicol Appl Pharmacol. 2015;289(1):124-132. doi: https://doi.org/10.1016/j.taap.2015.08.018; Maruo Y, Nishizawa K, Sato H, et al. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000;106(5):E59. doi: https://doi.org/10.1542/peds.106.5.e59; Fujiwara R, Chen S, Karin M, Tukey RH. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kB leads to hyperbilirubinemia. Gastroenterology. 2012;142(1): 109-118. doi: https://doi.org/10.1053/j.gastro.2011.09.045; Assenat E, Gerbal-Chaloin S, Larrey D, et al. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology. 2004;40(4):951-960. doi: https://doi.org/10.1002/hep.20387; Sumida K, Kawana M, Kouno E, et al. Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia. Mol Pharmacol. 2013;84(5): 679-686. doi: https://doi.org/10.1124/mol.113.088112; Ota Y Maruo Y Matsui K, et al. Inhibitory effect of 5e-pregnane-3a,20e-diol on transcriptional activity and enzyme activity of human bilirubin UDP-glucuronosyltransferase. Pediatr Res. 2011;70(5): 453-457. doi: https://doi.org/10.1203/PDR.0b013e31822f242e; Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician. 2014;89(11):873-878.; Xiao LL, Zhang XF, Wang XY. Changes in epidermal growth factor concentrations in neonates with late-onset breast milk jaundice after stopping breast feeding. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(12):1079-1081.; Fawaz R, Baumann U, Ekong U, et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):154-168. doi: https://doi.org/10.1097/MPG.0000000000001334; Banakar MK, Subbarayan A. A study of prolonged jaundice screen in healthy term babies. Indian J Clin Biochem. 2008;23(3):286-289. doi: https://doi.org/10.1007/s12291-008-0064-9; Kaplan M, Kaplan E, Hammerman C, et al. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child. 2006;91(1):31-34. https://doi.org/doi:10.1136/adc.2005.081224; Chang PW, Kuzniewicz MW, McCulloch CE, Newman TB. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy. Pediatrics. 2017;139(3):e20162896. doi: https://doi.org/10.1542/peds.2016-2896; So V, Coo H, Khurshid F. Validation of published rebound hyperbilirubinemia risk prediction scores during birth hospitalization after initial phototherapy: a retrospective chart review. Pediatr Res. 2022; 91(4):888-895. doi: https://doi.org/10.1038/s41390-021-01478-7; Sachdeva M, Murki S, Oleti TP, Kandraju H. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial. Eur J Pediatr. 2015; 174(2):177-181. doi: https://doi.org/10.1007/s00431-014-2373-8; Pettersson M, Eriksson M, Odlind A, Ohlin A. Home phototherapy of term neonates improves parental bonding and stress: findings from a randomized controlled trial. Acta Paediatr. 2022;111(4): 760-766. doi: https://doi.org/10.1111/apa.16231; Awad MH, Amer S, Hafez M, et al. Fenofibrate as an adjuvant to phototherapy in pathological unconjugated hyperbilirubinemia in neonates: a randomized control trial. J Perinatol. 2021;41(4): 865-872. doi: https://doi.org/10.1038/s41372-020-00861-2; Lazarus G, Francie J, Roeslani RD, et al. Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials. Ital J Pediatr. 2022; 48(1):179. doi: https://doi.org/10.1186/s13052-022-01372-w; Mutlu M, Aslan Y, Kader Ş, Aktürk Acar F. Preventive Effects of Probiotic Supplementation on Neonatal Hyperbilirubinemia Caused by Isoimmunization. Am J Perinatol. 2020;37(11):1173-1176. doi: https://doi.org/10.1055/s-0039-1692690; Nuzzi G, Trambusti I, DI Cicco ME, Peroni DG. Breast milk: more than just nutrition! Minerva Pediatr (Torino). 2021;73(2):111-114. doi: https://doi.org/10.23736/S2724-5276.21.06223-X; Geddes DT, Gridneva Z, Perrella SL, et al. 25 Years of Research in Human Lactation: From Discovery to Translation. Nutrients. 2021;13(9):3071. doi: https://doi.org/10.3390/nu13093071; Rahkonen P, Heinonen K, Pesonen AK, et al. Mother-child interaction is associated with neurocognitive outcome in extremely low gestational age children. Scand J Psychol. 2014;55(4): 311-318. doi: https://doi.org/10.1111/sjop.12133; Liu J, Leung P, Yang A. Breastfeeding and active bonding protects against children's internalizing behavior problems. Nutrients. 2013;6(1):76-89. doi: https://doi.org/10.3390/nu6010076; Vidavalur R, Devapatla S. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study. J Matern Fetal Neonatal Med. 2022;35(25):7701-7706. doi: https://doi.org/10.1080/14767058.2021.1960970; Alkén J, Håkansson S, Ekéus C, et al. Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden. JAMA Netw Open. 2019;2(3):e190858. doi: https://doi.org/10.1001/jamanetworkopen.2019.0858; McNamara RK, Vannest JJ, Valentine CJ. Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology. World J Psychiatry. 2015;5(1):15-34. doi: https://doi.org/10.5498/wjp.v5.i1.15; Anderson JW, Johnstone BM, Remley DT. Breast feeding and cognitive development: a meta-analysis. Am J Clin Nutr. 1999; 70(4):525-535. doi: https://doi.org/10.1093/ajcn/70.4.525; Kramer MS, Aboud F, Mironova E, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry. 2008;65(5):578-584. doi: https://doi.org/10.1001/archpsyc.65.5.578; Horta BL, Loret de Mola C, Victora CG. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):14-19. doi: https://doi.org/10.1111/apa.13139; Deoni SCL, Dean DC, Piryatinsky I, et al. Breastfeeding and early white matter development: A cross-sectional study. Neuroimage. 2013;82:77-86. doi: https://doi.org/10.1016/j.neuroimage.2013.05.090; Schött U, Solomon C, Fries D, Bentzer P The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand J Trauma Resusc Emerg Med. 2016; 24:48. doi: https://doi.org/10.1186/s13049-016-0239-y; Kutuzov N, Flyvbjerg H, Lauritzen M. Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier. Proc Natl Acad Sci USA. 2018;115(40): E9429-E9438. doi: https://doi.org/10.1073/pnas.1802155115; Liu B, Newburg DS. Human milk glycoproteins protect infants against human pathogens. Breastfeed Med. 2013;8(4):354-362. doi: https://doi.org/10.1089/bfm.2013.0016; Hassiotou F, Beltran A, Chetwynd E, et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells. 2012;30(10):2164-2174. doi: https://doi.org/10.1002/stem.1188; Velasco I, Santos C, Limon J, et al. Bioactive components in human milk along the first month of life: effects of iodine supplementation during pregnancy. Ann Nutr Metab. 2016;68(2):130-136. doi: https://doi.org/10.1159/000443800; Aydin MS, Yiğit EN, Vatandaşlar E, et al. Transfer and integration of breast milk stem cells to the brain of suckling pups. Sci Rep. 2018; 8(1):4289. doi: https://doi.org/10.1038/s41598-018-32715-5; Irmak MK, Oztas Y, Oztas E. Integration of maternal genome into the neonate genome through breast milk mRNA transcripts and reverse transcriptase. Theor Biol Med Model. 2012;9:20. doi: https://doi.org/10.1186/1742-4682-9-20; Păduraru L, Dimitriu DC, Avasiloaiei AL, et al. Total antioxidant status in fresh and stored human milk from mothers of term and preterm neonates. Pediatr Neonatol. 2018;59(6):600-605. doi: https://doi.org/10.1016/j.pedneo.2018.02.004; DiNicolantonio JJ, McCarty MF, O'Keefe JH. Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications. Open Heart. 2018;5(2):e000914. doi: https://doi.org/10.1136/openhrt-2018-000914; Hansen R, Gibson S, De Paiva Alves E, et al. Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin. Sci Rep. 2018;8(1):6470. doi: https://doi.org/10.1038/s41598-018-24811-3; Altuntaş N. Is There Any Effect of Hyperbilirubinemia on Breastfeeding? If Any, at Which Level? Breastfeed Med. 2020;15(1):29-34. doi: https://doi.org/10.1089/bfm.2019.0176; Huang Y, Chen L, Wang X, et al. Maternal knowledge, attitudes and practices related to neonatal jaundice and associated factors in Shenzhen, China: a facility-based cross-sectional study. BMJ Open. 2022;12(8):e057981. doi: https://doi.org/10.1136/bmjopen-2021-057981; Chu KH, Teng SW, Tai CJ, et al. Does Jaundice in Newborn Infants Affect Exclusivity and Duration of Breastfeeding in Taiwan? J Nurs Res. 2021;29(2):e145. doi: https://doi.org/10.1097/jnr.0000000000000420; Hokkanen L, Launes J, Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates — A 30 year prospective follow-up study. PeerJ. 2014;2:e294. doi: https://doi.org/10.7717/peerj.294; Tsao PC, Yeh HL, Shiau YS, et al. Long-term neurodevelopmental outcomes of significant neonatal jaundice in Taiwan from 20002003: A nationwide, population-based cohort study. Sci Rep. 2020; 10(1):11374. doi: https://doi.org/10.1038/s41598-020-68186-w; Chiu YW, Cheng SW, Yang CY, Weng YH. Breastfeeding in Relation to Neonatal Jaundice in the First Week After Birth: Parents' Perceptions and Clinical Measurements. Breastfeed Med. 2021; 16(4):292-299. doi: https://doi.org/10.1089/bfm.2020.0293; https://vsp.spr-journal.ru/jour/article/view/3351

الاتاحة: https://vsp.spr-journal.ru/jour/article/view/3351
https://doi.org/10.15690/vsp.v22i6.2656

المؤلفون: Olesya V. Zakharova, О. В. Захарова

المساهمون: Not specified., Отсутствует.

المصدر: Pediatric pharmacology; Том 21, № 2 (2024); 102-110 ; Педиатрическая фармакология; Том 21, № 2 (2024); 102-110 ; 2500-3089 ; 1727-5776

مصطلحات موضوعية: AMSTAR-2, hyperbilirubinemia, newborn, meta-epidemiological study, systematic review, гипербилирубинемия, новорожденный, метаэпидемиологическое исследование, систематический обзор

وصف الملف: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/2436/1580; Newman TB, Wu YW, Kuzniewicz MW, et al. Childhood Seizures After Phototherapy. Pediatrics. 2018;142(4):e20180648. doi: https://doi.org/10.1542/peds.2018-0648; Maimburg R, Olsen J, Sun Y. Neonatal hyperbilirubinemia and the risk of febrile seizures and childhood epilepsy. Women and Birth. 2013;26:S33. doi: https://doi.org/10.1016/j.wombi.2013.08.196; Abdellatif M, Tawfik GM, Makram AM, et al. Association between neonatal phototherapy and future cancer: an updated systematic review and meta-analysis. Eur J Pediatr. 2023;182(1):329–341. doi: https://doi.org/10.1007/s00431-022-04675-6; Nouri SAH, Zarkesh M. Recent Advances in Adjuvant Pharmacotherapy for Neonatal Indirect Hyperbilirubinemia: A Narrative Review. J Compr Ped. 2023;14(3):e136461. doi: https://doi.org/10.5812/compreped-136461; Володин Н.Н., Дегтярев Д.Н., Дегтярева А.В. и др. Тактика ведения доношенных и недоношенных новорожденных с непрямой гипербилирубинемией (клинические рекомендации) // Неонатология: Новости. Мнения. Обучение. — 2017. — № 2. — С. 113–126. — doi: https://doi.org/10.24411/2308-2402-2017-00035; Hoffmann F, Allers K, Rombey T, et al. Nearly 80 systematic reviews were published each day: Observational study on trends in epidemiology and reporting over the years 2000–2019. J Clin Epidemiol. 2021;138:1–11. doi: https://doi.org/10.1016/j.jclinepi.2021.05.022; Ioannidis JP. The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. Milbank Q. 2016;94(3):485–514. doi: https://doi.org/10.1111/1468-0009.12210; Pieper D, Hoffmann F. Retrieving Cochrane reviews is sometimes challenging and their reporting is not always optimal. Res Synth Methods. 2022;13(5):554–557. doi: https://doi.org/10.1002/jrsm.1564; Murad MH, Wang Z. Guidelines for reporting meta-epidemiological methodology research. Evid Based Med. 2017;22(4):139–142. doi: https://doi.org/10.1136/ebmed-2017-110713; Lefebvre C, Glanville J, Briscoe S, et al. Technical Supplement to Chapter 4: Searching for and selecting studies. In: Cochrane Handbook for Systematic Reviews of Interventions. Higgins JPT, Thomas J, Chandler J, et al., eds. Version 6.3 (updated October 2023). Cochrane, 2023.; R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2022. Available online: https://www.R-project.org. Accessed on February 23, 2024.; Grames EM, Stillman AN, Tingley MW, et al. litsearcher: An automated approach to identifying search terms for systematic reviews using keyword co-occurrence networks. Methods in Ecology and Evolution. 2019;10(10):1645–1654. doi: https://doi.org/10.1111/2041-210X.13268; Synnot A, Bragge P, Lunny C, et al. The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map. PLoS One. 2018;13(6):e0198676. doi: https://doi.org/10.1371/journal.pone.0198676; Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. doi: https://doi.org/10.1136/bmj.j4008; Квашнина Д.В., Полибин Р.В., Саперкин Н.В. и др. AMSTAR 2 — инструмент оценки качества систематических обзоров // Эпидемиология и Вакцинопрофилактика. — 2022. — Т. 21. — № 3. — С. 80–89. — doi: https://doi:10.31631/2073-3046-2022-21-3-80-89; Kuitunen I, Kiviranta P, Sankilampi U, et al. Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis. World J Pediatr. 2022;18(9):589– 597. doi: https://doi.org/10.1007/s12519-022-00563-z; Lazarus G, Francie J, Roeslani RD, et al. Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials. Ital J Pediatr. 2022;48(1):179. doi: https://doi.org/10.1186/s13052-022-01372-w; Huseynova RA. Effect of Ursodeoxycholic Acid in Unconjugated Hyperbilirubinemia in the Term Neonates Treated with Phototherapy: A Systematic Review. Int J Sci Res. 2022;1(4):356–367. doi: https://doi.org/10.5005/jp-journals-11002-0046; Wang G yan, Kong X bin, Gao Y. Meta-analysis of the Efficacy of Ursodeoxycholic Acid Combined with Blue Light in the Treatment of Neonatal Hyperbilirubinemia. Journal of Medical Information. 2023;36(17):34–39.; Hasan A. Effect of Ursodeoxycholic Acid in Lowering Neonatal Indirect Hyperbilirubinemia: A Randomized controlled trial. Merit Research Journal of Medicine and Medical Sciences. 2015;3(9):402–405.; Honar N, Ghashghaei Saadi E, Saki F, et al. Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy. J Pediatr Gastroenterol Nutr. 2016;62(1):97. doi: https://doi.org/10.1097/MPG.0000000000000874; Shahramian I, Tabrizian K, Ostadrahimi P, et al. Therapeutic Effects of Ursodeoxycholic Acid in Neonatal Indirect Hyperbilirubinemia: A Randomized Double-blind Clinical Trial. Archives of Anesthesiology and Critical Care. 2019;5(3):99–103. doi: https://doi.org/10.18502/aacc.v5i3.1211; El-Gendy F, Bahbah W, Al Kafory ES. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. Menoufia Med J. 2019;32(3):1059. doi: https://doi. org/10.4103/mmj.mmj_885_17; Akefi R, Hashemi SM, Alinejad S, et al. The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial. J Matern Fetal Neonatal Med. 2022;35(21):4075–4080. doi: https://doi.org/10.1080/14767058.2020.1846705; Behairy BES, Saber MA, Elsayed R, et al. Role of Ursodeoxycholic Acid in Lowering Indirect Hyperbilirubinemia in Neonates Under Phototherapy. Acta Sci Gastron Disord. 2020;3(10):07–1. 26. Gharehbaghi MM, Sani AM, Refeey M. Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice. Turk J Pediatr. 2020;62(3):424. doi: https://doi.org/10.24953/turkjped.2020.03.009; Dhillon SPS, Kaur N, Singh N, et al. To Study the Effect of Ursodeoxycholic Acid in Lowering Neonatal Non — Hemolytic Hyperbilirubinemia: A Randomized Control Study. Annals of International Medical and Dental Research. 2019;3(5):7–10. doi: https://doi.org/10.21276/aimdr.2019.5.2.PE2; Mirzarahimi M, Barak M, Moghaddam SS, et al. Effect of Ursodeoxycholic Acid (USDA) on Indirect Hyperbilirubinemia in Neonates Treated with Phototherapy. Progressing Aspects in Pediatrics and Neonatology. 2019;2(3):138–141. doi: https://doi.org/10.32474/PAPN.2019.02.000136; Jafari S, Khan KA, Bhatnagar S, et al. Role of ursodeoxycholic acid in neonates with indirect hyperbilirubinemia-an open labelled randomised control trial. Int J Contemp Pediatrics. 2018;5(2):432– 435. doi: https://doi.org/10.18203/2349-3291.ijcp20180530; Babaie E, Hassanpour K, Aldaghi M, et al. Comparison of the effect of ursodeoxycholic acid and multistrain synbiotic on indirect hyperbilirubinemia among neonates treated with phototherapy: A double-blind, randomized, placebo-controlled clinical trial study. J Res Med Sci. 2023;28:40. doi: https://doi.org/10.4103/jrms.jrms_894_21; Zadkarami M, Rahimpour F, Hardani AK, et al. Ursodeoxycholic acid and phototherapy versus phototherapy and placebo on neonatal indirect hyperbilirubinemia. Immunopathol Persa. 2023;x(x):35457. doi: https://doi.org/10.34172/ipp.2023.35457; Ratan NH, Hossain M, Hasan N, et al. A Comparative Study of Phototherapy Versus Phototherapy Plus Ursodeoxycholic Acid in the Treatment of Indirect Hyperbilirubinemia in Neonate. Annals of International Medical and Dental Research. 2022;8(4).; Ozdemir A, Kurtoglu S, Halis H, Bastug O. An Evaluation of Ursodeoxycholic Acid Treatment in Prolonged Unconjugated Hyperbilirubinemia due to Breast Milk. Niger J Clin Pract. 2023;26(9):1226. doi: https://doi.org/10.4103/njcp.njcp_216_22; García Rivera A. Efecto del ácido ursodesoxicólico en conjunto con fototerapia en el tratamiento de la hiperbilirrubinemia neonatal. [dissertation]. Universidad Autónoma de Nuevo León; 2019. Available online: http://eprints.uanl.mx/21733. Accessed on November 22, 2023.; Ughasoro MD, Adimorah GN, Chukwudi NK, et al. Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy. Clin Exp Gastroenterol. 2019;12:349–354. doi: https://doi.org/10.2147/CEG.S207523; Bhardwaj S, Gupta S, Jagrwal S, et al. Effect of Oral Ursodeoxycholic Acid on Indirect Hyperbilirubinemia In Neonates Treated With Phototherapy At Tertiary Care Centre, Jaipur. Eur J Mol Clin Med. 2020;7(11):5738–5747.; Ishani D, Karnawat B, Bohra M, et al. Therapeutic Role Of Ursodeoxycholic Acid In Management Of Neonates With Indirect Hyperbilirubinemia. Int J Sci Res. 2020;9(9):74–75. doi: https://doi.org/10.36106/ijsr; Yang X. Effect of Blue Light Therapy Combined with Ursodeoxycholic Acid on Serum Index and Curative Effect of Neonatal Jaundice. Chinese and Foreign Medical Research. 2021;19(34):155–158.; Tahir FN, Ahmad K, Irfan M, et al. Evaluating the Etiology of Prolonged Unconjugated Hyperbilirubinemia in Term Neonates admitted to Neonatal Wards: A Randomized Controlled Trial. Annals of Punjab Medical College (APMC). 2022;16(2):100–103. doi: https://doi.org/10.29054/apmc/2022.1318; Dawood ASMS, El-Sharkawy HM, Elsisi AEE, et al. Effect of ursodeoxycholic acid on indirect hyperbilirubinemia (nonhaemolytic and haemolytic) in neonates treated with phototherapy. Tanta Med J. 2022;50(3):173–176. doi: https://doi.org/10.4103/tmj.tmj_5_22; Rezaie M, Gholami R, Jafari M, et al. Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia. J Paediatr Child Health. 2021;57(8):1175– 1181. doi: https://doi.org/10.1111/jpc.15411; Farhadi R, Keyhanian E, Naderisorki M, et al. Effects of Two Different Doses of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates with Glucose-6-phosphate Dehydrogenase Deficiency Treated with Phototherapy: A Randomized Controlled Trial. Global Pediatric Health. 2023;10:2333794X231156055. doi: https://doi.org/10.1177/2333794X231156055; Olkin I, Gleser L. Stochastically dependent effect sizes. In: The handbook of research synthesis and meta-analysis. 2009. Vol. 2. pp. 357–376.; Uttley L, Quintana DS, Montgomery P, et al. The problems with systematic reviews: a living systematic review. J Clin Epidemiol. 2023;156:30–41. doi: https://doi.org/10.1016/j.jclinepi.2023.01.011; https://www.pedpharma.ru/jour/article/view/2436

الاتاحة: https://www.pedpharma.ru/jour/article/view/2436
https://doi.org/10.15690/pf.v21i2.2739

المؤلفون: E. Yu. Plotnikova, M. N. Sinkova, L. K. Isakov, Е. Ю. Плотникова, М. Н. Синькова, Л. К. Исаков

المصدر: Meditsinskiy sovet = Medical Council; № 8 (2024); 76-80 ; Медицинский Совет; № 8 (2024); 76-80 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: метаболический синдром, jaundice, hyperbilirubinemia, bilirubin-UDP-glucuronosyltransferase 1A1, metabolic syndrome, желтуха, гипербилирубинемия, билирубин-УДФ-глюкуронозилтрансфераза 1A1

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8344/7363; Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 2010;24(5):555–571. https://doi.org/10.1016/j.bpg.2010.07.007.; Vítek L. Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations? Arch Biochem Biophys. 2019;672:108062. https://doi.org/10.1016/j.abb.2019.108062.; Vítek L, Tiribelli C. Gilbert’s syndrome revisited. J Hepatol. 2023;79(4): 1049–1055. https://doi.org/10.1016/j.jhep.2023.06.004.; Sanyal AJ, Boyer TD, Lindor KD, Terrault NA. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. Elsevier; 2017.‎ 1072 p.; Hulzebos CV, Vitek L, Coda Zabetta CD, Dvořák A, Schenk P, van der Hagen EAE et al. Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments. Pediatr Res. 2021;90(2):277–283. https://doi.org/10.1038/s41390-021-01546-y.; Vitek L, Hinds TD Jr, Stec DE, Tiribelli C. The physiology of bilirubin: health and disease equilibrium. Trends Mol Med. 2023;29(4):315–328. https://doi.org/10.1016/j.molmed.2023.01.007.; Coltell O, Asensio EM, Sorlí JV, Barragán R, Fernández-Carrión R, Portolés O et al. Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population. Nutrients. 2019;11(1):90. https://doi.org/10.3390/nu11010090.; Coltell O, Sorlí JV, Asensio EM, Barragán R, González JI, Giménez-Alba IM et al. Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia. Front Genet. 2019;10:1073. https://doi.org/10.3389/fgene.2019.01073.; Vítek L, Tiribelli C. Bilirubin: The yellow hormone? J Hepatol. 2021;75(6):1485–1490. https://doi.org/10.1016/j.jhep.2021.06.010.; Vitek L, Bellarosa C, Tiribelli C. Induction of Mild Hyperbilirubinemia: Hype or Real Therapeutic Opportunity? Clin Pharmacol Ther. 2019;106(3):568–575. https://doi.org/10.1002/cpt.1341.; Lv X, Xia Y, Finel M, Wu J, Ge G, Yang L. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharm Sin B. 2019;9(2):258–278. https://doi.org/10.1016/j.apsb.2018.09.005.; Šuk J, Jašprová J, Biedermann D, Petrásková L, Valentová K, Křen V et al. Isolated silymarin flavonoids increase systemic and hepatic bilirubin concentrations and lower lipoperoxidation in mice. Oxid Med Cell Longev. 2019;2019:6026902. https://doi.org/10.1155/2019/6026902.; Liu XY, Lv X, Wang P, Ai CZ, Zhou QH, Finel M et al. Inhibition of UGT1A1 by natural and synthetic flavonoids. Int J Biol Macromol. 2019;126:653–661. https://doi.org/10.1016/j.ijbiomac.2018.12.171.; He YJ, Zhang W, Tu JH, Kirchheiner J, Chen Y, Guo D et al. Hepatic nuclear factor 1alpha inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin. Drug Metab Dispos. 2008;36(8):1453–1456. https://doi.org/10.1124/dmd.108.020503.; Chiang JYL, Ferrell JM. Bile Acids as Metabolic Regulators and Nutrient Sensors. Annu Rev Nutr. 2019;39:175–200. https://doi.org/10.1146/annurev-nutr-082018-124344.; Vítek L. Bilirubin and atherosclerotic diseases. Physiol Res. 2017;66(1):11–20. https://doi.org/10.33549/physiolres.933581.; Seyed Khoei N, Grindel A, Wallner M, Mölzer C, Doberer D, Marculescu R et al. Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health. Atherosclerosis. 2018;269:306–311. https://doi.org/10.1016/j.atherosclerosis.2017.12.021.; DiNicolantonio JJ, McCarty M, OKeefe J. Does elevated bilirubin aid weight control by preventing development of hypothalamic leptin resistance? Open Heart. 2019;6(1):e000897. https://doi.org/10.1136/openhrt-2018-000897.; DiNicolantonio JJ, McCarty MF, O’Keefe JH. Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications. Open Heart. 2018;5(2):e000914. https://doi.org/10.1136/openhrt-2018-000914.; Petrtýl J, Dvořák K, Stříteský J, Leníček M, Jirásková A, Šmíd V et al. Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel). 2021;10(12):2000. https://doi.org/10.3390/antiox10122000.; Bianco A, Tiribelli C, Bellarosa C. Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. Biomedicines. 2022;10(3):696. https://doi.org/10.3390/biomedicines10030696.; Vitek L, Hubacek JA, Pajak A, Doryńska A, Kozela M, Eremiasova L et al. Association between plasma bilirubin and mortality. Ann Hepatol. 2019;18(2):379–385. https://doi.org/10.1016/j.aohep.2019.02.001.; Chmielewski P, Strzelec B, Chmielowiec J, Chmielowiec K, Borysławski K. Association of serum bilirubin with longevity: evidence from a retrospective longitudinal study and cross-sectional data. Anthropol Rev. 2017;80(4):335–348. https://doi.org/10.1515/anre-2017-0024.; Toth CCZ. Gilbert’s syndrome sucessfully treated with the paleolithic ketogenic diet. Am J Med Case Rep. 2015;3:117–120. https://doi.org/10.12691/ajmcr-3-4-9.; Woronyczová J, Nováková M, Leníček M, Bátovský M, Bolek E, Cífková R, Vítek L. Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes. Sports Med Open. 2022;8(1):84. https://doi.org/10.1186/s40798-022-00463-6.; Flack KD, Vítek L, Fry CS, Stec DE, Hinds TDJr. Cutting edge concepts: Does bilirubin enhance exercise performance? Front Sports Act Living. 2023;4:1040687. https://doi.org/10.3389/fspor.2022.1040687.; Buyukasik Y, Akman U, Buyukasik NS, Goker H, Kilicarslan A, Shorbagi AI et al. Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert’s syndrome. Am J Med Sci. 2008;335(2):115– 159. https://doi.org/10.1097/MAJ.0b013e318142be0d.; Kundur AR, Santhakumar AB, Bulmer AC, Singh I. Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert’s syndrome. Platelets. 2017;28(8):779–785. https://doi.org/10.1080/09537104.2017.1280146.; https://www.med-sovet.pro/jour/article/view/8344

الاتاحة: https://www.med-sovet.pro/jour/article/view/8344
https://doi.org/10.21518/ms2024-212

المؤلفون: Бобоева Нигора Тухтамишевна

المصدر: GOLDEN BRAIN, 1(13), 156-160, (2023-05-15)

مصطلحات موضوعية: новорожденные, билирубин, пролонгированная гипербилирубинемия, физиологические рефлексы, дыхательная недостаточность, вегето-висцеральный синдром

Relation: https://doi.org/10.5281/zenodo.7940211; https://zenodo.org/communities/golden_brain; https://doi.org/10.5281/zenodo.7940210; oai:zenodo.org:7940211

الاتاحة: https://doi.org/10.5281/zenodo.7940211

المؤلفون: Krasnoyarova, M. V., Mezina, M. V., Zhienbayeva, M. M., Kuznetsov, N. N., Красноярова, М. В., Мезина, М. В., Жиенбаева, М. М., Кузнецов, Н. Н.

المصدر: Сборник статей

مصطلحات موضوعية: GALACTOSEMIA, ORPHAN DISEASE, HEMORRHAGIC SYNDROME, MULTIPLE ORGAN DISORDERS, HYPERBILIRUBINEMIA, ГАЛАКТОЗЕМИЯ, ОРФАННОЕ ЗАБОЛЕВАНИЕ, ГЕМОРРАГИЧЕСКИЙ СИНДРОМ, ПОЛИОРГАННЫЕ НАРУШЕНИЯ, ГИПЕРБИЛИРУБИНЕМИЯ

وصف الملف: application/pdf

Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г.; Клинические случаи наследственной галактоземии у новорожденных / М. В. Красноярова, М. В. Мезина, М. М. Жиенбаева, Н. Н. Кузнецов. - Текст электронный. // Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г. – Екатеринбург : УГМУ, 2023. – C. 2424-2429.; http://elib.usma.ru/handle/usma/14359

الاتاحة: http://elib.usma.ru/handle/usma/14359

المؤلفون: A. A. Ivanova, A. A. Gurazheva, E. S. Mel’nikova, V. N. Maksimov, E. G. Nemcova, А. А. Иванова, А. А. Гуражева, Е. С. Мельникова, В. Н. Максимов, Е. Г. Немцова

المساهمون: The study was carried out with the financial support of the Government of the Novosibirsk region within the framework of the State Budget No. 122031700094-5 of Research Institutе of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences., Исследование выполнено при финансовой поддержке Правительства Новосибирской области в рамках ГЗ № 122031700094-5.

المصدر: Bulletin of Siberian Medicine; Том 22, № 2 (2023); 39-45 ; Бюллетень сибирской медицины; Том 22, № 2 (2023); 39-45 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2023-22-2

مصطلحات موضوعية: неконъюгированная гипербилирубинемия, rs3064744, rs34993780, rs56059937, rs4148323, rs4124874, UGT1A1 gene, unconjugated hyperbilirubinemia, ген UGT1А1

وصف الملف: application/pdf

Relation: https://bulletin.ssmu.ru/jour/article/view/5218/3391; https://bulletin.ssmu.ru/jour/article/view/5218/3414; King D., Armstrong M.J. Overview of Gilbert’s syndrome. Drug Ther. Bull. 2019;57(2):27–31. DOI:10.1136/dtb.2018.000028. PMID: 30709860.; Kringen M.K., Piehler A.P., Grimholt R.M., Opdal M.S., Haug K.B., Urdal P. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants. PLoS One. 2014;9(2):e90248. DOI:10.1371/journal.pone.0090248.; Maruo Y., D’Addario C., Mori A., Iwai M., Takahashi H., Sato H. et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum. Genet. 2004;115(6):525–526. DOI:10.1007/s00439-004-1183-x.; Steventon G. Uridine diphosphate glucuronosyltransferase 1A1. Xenobiotica. 2020;50(1):64–76. DOI:10.1080/00498254.2019.1617910.; Gazzin S., Masutti F., Vitek L., Tiribelli C. The molecular basis of jaundice: An old symptom revisited. Liver Int. 2017;37(8):1094–1102. DOI:10.1111/liv.13351.; Udomuksorn W., Elliot D.J., Lewis B.C., Mackenzie P.I., Yoovathaworn K., Miners J.O. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007;17(12):1017–1029. DOI:10.1097/FPC.0b013e328256b1b6.; Zhou J., Yang C., Zhu W., Chen S., Zeng Y., Wang J. et al. Identification of Genetic Risk Factors for Neonatal Hyperbilirubinemia in Fujian Province, Southeastern China: A Case-Control Study. Biomed. Res. Int. 2018;2018:7803175. DOI:10.1155/2018/7803175.; Bale G., Avanthi U.S., Padaki N.R., Sharma M., Duvvur N.R., Vishnubhotla V.R.K. Incidence and risk of gallstone disease in Gilbert’s syndrome patients in indian population. J. Clin. Exp. Hepatol. 2018;8(4):362–366. DOI:10.1016/j.jceh.2017.12.006.; Sugatani J., Yamakawa K., Yoshinari K., Machida T., Takagi H., Mori M. et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem. Biophys. Res. Commun. 2002;292(2):492– 497. DOI:10.1006/bbrc.2002.6683.; https://bulletin.ssmu.ru/jour/article/view/5218

الاتاحة: https://bulletin.ssmu.ru/jour/article/view/5218
https://doi.org/10.20538/1682-0363-2023-2-39-45

المؤلفون: Н. Н. Силивончик, Т. Н. Якубчик, О. А. Жигальцова-Кучинская

المصدر: Гепатология и гастроэнтерология, Vol 7, Iss 1, Pp 15-20 (2023)

مصطلحات موضوعية: неконьюгированная гипербилирубинемия, синдром жильбера, синдром криглера-найяра, ugt1a1, Diseases of the digestive system. Gastroenterology, RC799-869

Relation: http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/296; https://doaj.org/toc/2616-5546; https://doaj.org/toc/2708-5309; https://doaj.org/article/d81b6871e5d04e85897e5550a67737a2

الاتاحة: https://doi.org/10.25298/2616-5546-2023-7-1-15-20
https://doaj.org/article/d81b6871e5d04e85897e5550a67737a2

المؤلفون: П. Е. Ткаченко, В. Т. Ивашкин, М. В. Маевская

المصدر: Malignant tumours; Том 12, № 3s2-2 (2022); 64-77 ; Злокачественные опухоли; Том 12, № 3s2-2 (2022); 64-77 ; 2587-6813 ; 2224-5057

مصطلحات موضوعية: химиотерапия, гипербилирубинемия, печёночная недостаточность

وصف الملف: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1064/760; https://www.malignanttumors.org/jour/article/view/1064

الاتاحة: https://www.malignanttumors.org/jour/article/view/1064
https://doi.org/10.18027/2224-5057-2022-12-3s2-64-77

المؤلفون: Kitova, T. A., Krutin, I. V., Myshinskaya, O. I., Китова, Т. А., Крутинь, И. В., Мышинская, О. И.

المصدر: Сборник статей

مصطلحات موضوعية: NEWBORNS, HYPERBILIRUBINEMIA, METABOLIC DISORDERS, НОВОРОЖДЕННЫЕ, ГИПЕРБИЛИРУБИНЕМИЯ, МЕТАБОЛИЧЕСКИЕ НАРУШЕНИЯ

وصف الملف: application/pdf

Relation: Актуальные вопросы современной медицинской науки и здравоохранения: Материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021): в 3-х т.; Китова, Т. А. Предикторы патологической гипербилирубинемии у новорожденных детей / Т. А. Китова, И. В. Крутинь, О. И. Мышинская // Актуальные вопросы современной медицинской науки и здравоохранения: материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021 г.) : в 3-х т. – Екатеринбург : УГМУ, 2021. – Т.2. – С. 337-343.; http://elib.usma.ru/handle/usma/5421

الاتاحة: http://elib.usma.ru/handle/usma/5421

المؤلفون: Фесенко, Марія Євгенівна, Цвіренко, Світлана Миколаївна, Щербань, Олена Анатоліївна, Козакевич, Вероніка Клавдіївна, Лебедєва, Тетяна Миколаївна, Фесенко, Мария Евгеньевна, Цвиренко, Светлана Николаевна, Щербань, Елена Анатолиевна, Козакевич, Вероника Клавдиевна, Лебедева, Татьяна Николаевна, Fesenko, M. Yе., Tsvirenko, S. M., Scherban, O. A., Kozakevych, V. K., Liebiedieva, T. M.

مصطلحات موضوعية: синдром Жильбера, гіпербілірубінемія, новонароджена дитина, гипербилирубинемия, новорожденный ребенок, Gilbert's syndrome, hyperbilirubinemia, a newborn, 616.36 008.5 053.31

Relation: Синдром Жильбера в новонародженої дитини (клінічний випадок) / М. Є. Фесенко, С. М. Цвіренко, О. А. Щербань, В. К. Козакевич, Т. М. Лебедєва // Сучасна педіатрія. – 2021. – Вип. 3 (115). – С. 79–82.; http://repository.pdmu.edu.ua/handle/123456789/16504

الاتاحة: http://repository.pdmu.edu.ua/handle/123456789/16504

المؤلفون: П. Ткаченко Е., В. Ивашкин Т., М. Маевская В.

المصدر: Malignant tumours; Том 11, № 3s2-2 (2021); 64-77 ; Злокачественные опухоли; Том 11, № 3s2-2 (2021); 64-77 ; 2587-6813 ; 2224-5057

مصطلحات موضوعية: Гепатотоксичность, гипербилирубинемия, печёночная недостаточность, химиотерапия

وصف الملف: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/892/640; https://www.malignanttumors.org/jour/article/view/892

الاتاحة: https://www.malignanttumors.org/jour/article/view/892
https://doi.org/10.18027/2224-5057-2021-11-3s2-40

المؤلفون: L. Yu. Ilchenko, I. G. Fedorov, G. G. Totolyan, A. G. Tsvetkova, E. G. Gavrilenko, K. O. Mironov, I. G. Nikitin

المصدر: Гепатология и гастроэнтерология, Vol 5, Iss 1, Pp 79-84 (2021)

مصطلحات موضوعية: синдром криглера-найяра ii типа, синдром жильбера, неконъюгированная гипербилирубинемия, ген уридин-5'-дифосфат (udp) -глюкуронозилтрансферазы, Diseases of the digestive system. Gastroenterology, RC799-869

Relation: http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/187; https://doaj.org/toc/2616-5546; https://doaj.org/toc/2708-5309; https://doaj.org/article/f20e9c6d19bf40fb8be288a947f0d56a

الاتاحة: https://doi.org/10.25298/2616-5546-2021-5-1-79-84
https://doaj.org/article/f20e9c6d19bf40fb8be288a947f0d56a

المؤلفون: L. Melnikova I., L. Ilchenko Yu., E. Dunaeva A., M. Kozitsyna V., O. Dribnokhodova P., K. Mironov O., P. Izhevskiy V., V. Nikishin V., Л. Мельникова И., Л. Ильченко Ю., Е. Дунаева А., М. Козицына В., О. Дрибноходова П., К. Миронов О., П. Ижевский В., В. Никишин В.

المصدر: Medical Genetics; Том 19, № 7 (2020); 99-100 ; Медицинская генетика; Том 19, № 7 (2020); 99-100 ; 2073-7998

مصطلحات موضوعية: Gilbert’s syndrome, hyperbilirubinemia, uridine-diphosphate glucuronosyltransferase 1А1 (UGT1A1), pyrosequencing, синдром Жильбера, гипербилирубинемия, уридиндифосфат-глюкуронилтрансфераза 1А1 (УГТ1А1), пиросеквенирование

وصف الملف: application/pdf

Relation: https://www.medgen-journal.ru/jour/article/view/1463/1105; https://www.medgen-journal.ru/jour/article/view/1463

الاتاحة: https://www.medgen-journal.ru/jour/article/view/1463
https://doi.org/10.25557/2073-7998.2020.07.99-100

مصطلحات موضوعية: новорожденные, билирубин, пролонгированная гипербилирубинемия, физиологические рефлексы, дыхательная недостаточность, вегето-висцеральный синдром

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5450980a3da99ae719df2eadd711f5f9

المؤلفون: L. I. Melnikova, L. Yu. Ilchenko, E. A. Dunaeva, M. V. Kozitsyna, O. P. Dribnokhodova, K. O. Mironov, Л. И. Мельникова, Л. Ю. Ильченко, Е. А. Дунаева, М. В. Козицына, О. П. Дрибноходова, К. О. Миронов

المصدر: The Russian Archives of Internal Medicine; Том 9, № 6 (2019); 475-482 ; Архивъ внутренней медицины; Том 9, № 6 (2019); 475-482 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2019-9-6

مصطلحات موضوعية: пиросеквенирование, hyperbilirubinemia, uridine-5-diphosphate glucuronosyltransferase 1A1 (UDP-GTA1), pyrosequencing Conflict of interest, гипербилирубинемия, уридиндифосфат-глюкуронилтрансфераза 1А1 (УГТ1А1)

وصف الملف: application/pdf

Relation: https://www.medarhive.ru/jour/article/view/987/857; https://www.medarhive.ru/jour/article/view/987/867; Gilbert A.N., Lereboullet P. La cholemie simple familiale. Semaine Medicale. 1901; 21: 241-3.; Ильченко Л.Ю., Дроздов В.Н., Шулятьев И.С. и др. Синдром Жильбера: клинико-генетическое исследование. Тер. архив. 2006; 2: 48-2.; Wagner K.H., Shiels R.G., Llang C.A. et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit. Rev. Clin. Lab. Sci. 2018;55(2):129-39. doi:10.1080/10408363.2018.1428526.; Innocenti F., Ratain M.J. Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park, N.Y.). 2003; 17(5): 52-5.; Farago B., Melegh B. Gilbert's syndrome. Orv. Hetil. 2008; 149(27): 1277-2. doi:10.1556/OH.2008.28381.; Рейзис А.Р, Хохлова О.Н., Никитина Т.С. Синдром Жильбера: современные воззрения, исходы и терапия. Доктор Ру. 2012; 3(71): 42-5.; Johnson A.D., Kavousi M., Smith A.V, et al. Genome-wide association meta-analysis for total serum bilirubin levels. Human Molecular Genetics. 2009; 18(14): 2700-10. doi:10.1093/hmg/ddp202.; Muraca M., Fevery J. Influence of sex and sex steroids on bilirubin-uridinediphosphateglucuronosyltransferase activity of rat liver. Gastroenterology. 1984; 87: 308-3.; Lee J.S., Wang J., Martin M. et al. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab. Pharmacogenet. Genomics. 2011; 21(7): 365-4. doi:10.1097/FPC.0b013e32834592fe.; Mackenzie P.I., Owens I.S., Burchell B. et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 1997; 7(4): 255-69. doi:10.1097/00008571-199708000-00001.; Matsui K., Maruo Y., Sato H. et al. Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of Gilbert syndrome. BMC Gastroenterology. 2010; 10: 57. doi:10.1186/1471-230X-10-57; Sugatani J. Function, genetic polymorphism, and transcriptional regulation of human UDP-glucuronosyltransferase (UGT) 1A1. Drug Metab. Pharmacokinet. 2013; 28(2): 83-2.; Герок В., Блюм Х.Е. Заболевания печени и желчевыделительной системы. М.: «МЕДпресс-информ». 2009; 199 с.; Bock K.W., Gschaidmeier H., Heel H. et al. Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metab. Rev. 1999; 31(2): 411-22. doi:10.1081/DMR-100101927.; Sangеr F., Nicklen S., Coulson A.R. DNA sequencing with chainterminating ingibtors. Proc. Natl. Acad. Sci. USA. 1977; 74(12): 5463-7. DOI:10.1073/pnas.74.12.5463.; Nyren P. The History of Pyrosequencing. Methods Mol. Biol. 2015; 1315: 3-15. doi:10.1007/978-1-4939-2715-9_1.; Дрибнохотова О.П., Миронов К.О., Дунаева Е.А. и др. Определение полиморфизма (ТА)6(ТА)7 в гене UGT1A1 методом пиросекве-нирования. Молекулярная медицина. 2014; 2: 38-40.; Волков А.Н., Цуркан Е.В. Мутация гена UGT1A1 как маркер высокого риска возникновения синдрома Жильбера: научноприкладные аспекты. Анализ риска здоровью. 2019; 2: 123-9. doi:10.21668/health.risk/2019.2.14.; Колюбаева С.Н., Кулагина К.О, Петрова И.С., Криворучко А.Б., Иванов А.М. Молекулярно-генетическая диагностика синдрома Жильбера методом пиросеквенирования. Поликлиника. 2016; 1(3): 4-6.; Дубровина Г.М., Ботвиньев О.К., Колотилина А.И. Сочетание синдрома Жильбера с заболеваниями желудочно-кишечного тракта. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014; 3: 13-1.; Dutt M.K., Murphy G.M., Thompson R.P. Unconjugated bilirubin in human bile: the nucleating factor in cholesterol cholelithiasis? J. Clin. Pathol. 2003; 56: 596-8. doi:10.1136/jcp.56.8.596.; Tsezou A., Tzetis M.,Giannatou E. et al. Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population. Genet. Test. Mol. Biomarkers. 2009; 13(1): 143-6. doi:10.1089/gtmb.2008.0095.; Buch S., Schafmayer C., Volzke H. et al. Loci from a genome-wide analyses of bilirubin levels are associated with gallstone risk and composition. Gastroenterology. 2010; 139(6): 1942-1. doi:10.1053/j.gastro.2010.09.003.; Radlovic N., Ristic D., Brdar R. Association of hereditary elliptocytosis and Gilbert's syndrome as the cause of biliary calculosis: case report. Srpski arhiv za celokupno lekarstvo. 2011; 139(5-6): 386-9.; Horsfall L.J., Nazareth I., Pereira S.P. et al. Gilbert's syndrome and the risk of death: a population-based cohort study. J. Gastroenterol. Hepatol. 2013; 28(10): 1643-7. doi:10.1111/jgh.12279.; Ginsburg G.S., McCarthy J.J. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol. 2001; 19: 491-6.; Deterding K., Grungreiff K., Lankisch T.O. et al. Gilbert's syndrome and antiviral therapy of hepatitis C. Ann. Hepatol. 2009; 8(3): 246-50.; McDonald G.B., Evans A.T., McCune J.S. et al. Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study. Lancet Haematol. 2016; 3(11): e516-e525. doi:10.1016/S2352-3026(16)30149-1.; https://www.medarhive.ru/jour/article/view/987

الاتاحة: https://www.medarhive.ru/jour/article/view/987
https://doi.org/10.20514/2226-6704-2019-9-6-475-482

المؤلفون: Kalyakova, N. V., Ganbarova, H. А., Bashirova, N. A., Filippova, O. A., Калякова, Н. В., Ганбарова, Х. А., Баширова, Н. А., Филиппова, О. А., Кузнецов Н. Н.

المصدر: Сборник статей

مصطلحات موضوعية: CONJUGATION HYPERBILIRUBINEMIA, RISK FACTORS, JAUNDICE, КОНЪЮГАЦИОННАЯ ГИПЕРБИЛИРУБИНЕМИЯ, ФАКТОРЫ РИСКА, ЖЕЛТУХА

وصف الملف: application/pdf

Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей IV Международной научно-практической конференции молодых учёных и студентов, IV Всероссийского форума медицинских и фармацевтических вузов «За качественное образование», (Екатеринбург, 10-12 апреля 2019): в 3-х т. - Екатеринбург: УГМУ, CD-ROM.; Факторы риска конъюгационной желтухи у новорожденных и детей грудного возраста. / Н. В. Калякова, Х. А. Ганбарова, Н. А. Баширова [и др.] // Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей IV Международной научно-практической конференции молодых учёных и студентов, IV Всероссийского форума медицинских и фармацевтических вузов «За качественное образование», (Екатеринбург, 10-12 апреля 2019): в 3-х т. - Екатеринбург: УГМУ, CD-ROM. – 2019. – Т.2. – С.485-489.; http://elib.usma.ru/handle/usma/4169

الاتاحة: http://elib.usma.ru/handle/usma/4169

المؤلفون: G. T. Sukhikh, A. V. Degtyareva, D. N. Silachev, K. V. Gorunov, I. V. Dubrovina, L. V. Ushakova, D. N. Degtyarev, Г. Т. Сухих, А. В. Дегтярева, Д. Н. Силачев, К. В. Горюнов, И. В. Дубровина, Л. В. Ушакова, Д. Н. Дегтярев

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 64, № 4 (2019); 26-34 ; Российский вестник перинатологии и педиатрии; Том 64, № 4 (2019); 26-34 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2019-64-4

مصطلحات موضوعية: фототерапия, Crigler–Naiar syndrome, hyperbilirubinemia, multipotent mesenchymal stromal cells, phototherapy, синдром Криглера–Найара, гипербилирубинемия, мультипотентные мезенхимальные стромальные клетки

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/924/801; Crigler J.F., Najjar V.A. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952; 10: 169–180.; Servedio V., d’Apolito M., Maiorano N., Minuti B., Torricelli F., Ronchi F. et al. Spectrum of UGT1A1 mutations in Crigler–Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum. Mutat 2005; 25: 325–329. DOI:10.1002/9322; Haustein M.D., Read D.J., Steinert J.R., Pilati N., Dinsdale D., Forsythe I.D. Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J Physiol (Lond.) 2010; 588: 4683–4693. DOI:10.1113/jphysiol.2010.199778; Hachiya Y., Hayashi M. Bilirubin encephalopathy: a study of neuronal subpopulations and neurodegenerative mechanisms in 12 autopsy cases. Brain Dev 2008; 30: 269–278. DOI:10.1016/j.braindev.2007.08.013; Володин Н.Н., Дегтярев Д.Н., Дегтярева А.В., Нароган М.В. Желтухи новорожденных. М.: ГЭОТАР-Медиа, 2019; 192.; Дегтярев Д.Н, Иванова (Дегтярева) А.В., Сигова Ю.А. Синдром Криглера–Найара. Российский вестник перинатологии и педиатрии 1998; 4: 44–48.; Fox I.J., Chowdhury J.R. Hepatocyte transplantation. Am J Transplant 2004; 4(Suppl 6): 7–13. DOI:10.1016/j. jhep.2004.04.009; Dhawan A., Mitry R.R., Hughes R.D. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 2006; 29: 431–435. DOI:10.1007/s10545-006-0245-8; Silachev D.N., Kondakov A.K., Znamenskii I.A., Kurashvili Y.B., Abolenskaya A.V., Antipkin N.R. et al. The Use of Technetium-99m for Intravital Tracing of Transplanted Multipotent Stromal Cells. Bull Exp Biol Med 2016; 162: 153–159. DOI:10.1007/s10517-016-3565-1; Zhang Z., Lin H., Shi M., Xu R., Fu J. et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012; 27(Suppl 2): 112–120. DOI:10.1111/j.1440-1746.2011.07024.x; Alfaifi M., Eom Y.W., Newsome P.N., Baik S.K. Mesenchymal stromal cell therapy for liver diseases. J Hepatol 2018; 68: 1272–1285. DOI:10.1016/j.jhep.2018.01.030; Lim R. Concise Review: Fetal Membranes in Regenerative Medicine: New Tricks from an Old Dog? Stem Cells Transl Med 2017; 6: 1767–1776. DOI:10.1002/sctm.16-0447; Toyserkani N.M., Jørgensen M.G., Tabatabaeifar S., Jensen C.H., Sheikh S.P., Sørensen J.A. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Transl Med 2017; 6: 1786–1794. DOI:10.1002/sctm.17-0031; Ribes-Koninckx C., Ibars E.P., Calzado Agrasot M.Á., BonoraCentelles A., Miquel B.P., Vila Carbó J.J. et al. Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant 2012; 21: 2267–2282. DOI:10.3727/096368912X637505; Tolosa L., Pareja-Ibars E., Donato M.T., Cortés M., López S., Jiménez N. et al. Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation. Cell Transplant 2014; 23: 1229–1242. DOI:10.3727/096368913X669743; Tsuchiya A., Kojima Y., Ikarashi S., Seino S., Watanabe Y., Kawata Y., Terai S. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regen 2017; 37: 16. DOI:10.1186/s41232-017-0045-6; Tolosa L., López S., Pareja E., Donato M.T., Myara A., Nguyen T.H. et al. Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat. Liver Transpl 2015; 21: 801–811. DOI:10.1002/lt.24121; Kobayashi K., Suzuki K. Mesenchymal Stem/Stromal CellBased Therapy for Heart Failure – What Is the Best Source? Circ J 2018; 82: 2222–2232. DOI:10.1253/circj.CJ-18-0786; Kwon A., Kim Y., Kim M., Kim J., Choi H., Jekarl D.W. et al. Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues. Sci Rep 2016; 6: 23544. DOI:10.1038/srep23544; Fitzpatrick E., Wu Y., Dhadda P., Hughes R.D., Mitry R.R., Qin H. et al. Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transplant 2015; 24: 73–83. DOI:10.3727/096368913X674080; Campard D., Lysy P.A., Najimi M., Sokal E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008; 134(3): 833–848. DOI:10.3390/cells1041061 Sep 07, 2014; Bishi D.K., Mathapati S., Venugopal J.R., Guhathakurta S., Cherian K.M., Verma R.S., Ramakrishna S.A. Patient-Inspired Ex Vivo Liver Tissue Engineering Approach with Autologous Mesenchymal Stem Cells and Hepatogenic Serum. Adv Healthc Mater 2016; 5: 1058–1070. DOI:10.1002/adhm.201500897; Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T. et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58: 570–581. DOI:10.1136/gut.2008.154880; Jin S.-Z., Liu B.-R., Xu J., Gao F.-L., Hu Z.-J., Wang X.-H. et al. Ex vivo-expanded bone marrow stem cells home to the liver and ameliorate functional recovery in a mouse model of acute hepatic injury. Hepatobiliary Pancreat Dis Int 2012; 11(1): 66–73. DOI:10.1016/S1499-3872(11)60127-6; Falcão A.S., Silva R.F.M., Vaz A.R., Gomes C., Fernandes A., Barateiro A. et al. Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts. Neurotox Res 2014; 26: 1–15. DOI:10.1007/s12640-013-9427-y; Amini N., Vousooghi N., Hadjighassem M., Bakhtiyari M., Mousavi N., Safakheil H. et al. Efficacy of Human Adipose Tissue-Derived Stem Cells on Neonatal Bilirubin Encephalopathy in Rats. Neurotox Res 2016; 29: 514–524. DOI:10.1007/s12640-016-9599-3; Uccelli A., Benvenuto F., Laroni A., Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011; 24: 59–64. DOI:10.1016/j.beha.2011.01.004; Katagiri H., Kushida Y., Nojima M., Kuroda Y., Wakao S., Ishida K. et al. A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components. Am J Transplant 2016; 16: 468–483. DOI:10.1111/ajt.13537.; Kuo T.K., Hung S.-P., Chuang C.-H., Chen C.-T., Shih Y. R.V., Fang S.-C.Y. et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134: 2111– 2121, 2121.e1–3. DOI:10.1053/j.gastro.2008.03.015; Wang L., Li J., Liu H., Li Y., Fu J., Sun Y. et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2013; 28(Suppl 1): 85–92. DOI:10.1111/jgh.12029; https://www.ped-perinatology.ru/jour/article/view/924

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/924
https://doi.org/10.21508/1027-4065-2019-64-4-26-34

المؤلفون: Yu. Hodovanets, Yu. Volosivska, L. Agafonova

المصدر: Неонатологія, хірургія та перинатальна медицина, Vol 8, Iss 4(30) (2018)

مصطلحات موضوعية: новорожденный, желтуха, гипербилирубинемия, этиология, патогенез, патоморфология, Pediatrics, RJ1-570, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

Relation: http://neonatology.bsmu.edu.ua/article/view/151065; https://doaj.org/toc/2226-1230; https://doaj.org/toc/2413-4260

URL الوصول: https://doaj.org/article/6f6ca8bb7e3c442f9dbd194dc8ed305e

المؤلفون: S. Zhdanova I., L. Vakhitova F., O. Polyakova I., С. Жданова И., Л. Вахитова Ф., О. Полякова И.

المصدر: Meditsinskiy sovet = Medical Council; № 2 (2018); 58-62 ; Медицинский Совет; № 2 (2018); 58-62 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2018-2

مصطلحات موضوعية: neonatal hyperbilirubinemia, hemolytic disease of the newborn, breastfeeding, jaundice because of variations in the composition of the breast milk, jaundice associated with breastfeeding, неонатальная гипербилирубинемия, гемолитическая болезнь новорожденного, грудное вскармливание, желтуха от состава грудного молока, желтуха от грудного вскармливания

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/2288/2271; World Health Organization. Global Strategy on Infant and Young Child Feeding. Geneva, Switzerland: World Helath Organization, 2003.; Seagraves K, Brulte A, McNeely K, Pritham U. Supporting Breastfeeding to Reduce Newborn Readmissions for Hyperbilirubinemia. Nurs Womens Health, 2013, 17(6): 498–507.; Yang WC, Zhao LL, Li YC, Chen CH, Chang YJ, Fu YC, et al. Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatr, 2013, 13: 145.; Абольян Л.В., Новикова С.В. Современные аспекты грудного вскармливания Педиатрия, 2011, 90(1)6: 80-83.; Chou RH, Palmer RH, Ezhuthachan S, et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics, 2003, 112: 1264–73.; American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 2004, 114: 297–316.; Володин Н.Н., Дегтярев Д.Н., Дегтярева А.В., Карпова А.Л., Мебелова И.И., Пруткин М.Е., Сенькевич О.А., Харламова Н.В. Тактика ведения доношенных и недоношенных новорожденных с непрямой гипербилирубинемией (клинические рекомендации). Неонатология: новости, мнения, обучение, 2017, 2: 113-126.; Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации. М., 2010.; Избранные клинические рекомендации по неонатологии. Под ред. Е.Н. Байбариной, Д.Н. Дегтярева. М.: ГЭОТАР-Медиа, 2016.; Гемолитическая болезнь плода и новорожденного (ГБН). Клинические рекомендации. М., 2017.; Arias IM, Gartner LM, Seifter S. Neonatal unconjugated hyperbilirubinemia associated with breastfeeding and a factor in milk that inhibits glucuronide formation in vitro. J. Clin. Invest., 1963, 42: 913.; Newman AJ, Gross S. Hyperbilirubinemia in breast-fed infants. Pediatrics, 1963, 32: 995–1001.; Arias IM, Gartner LM, Seifter S, Furman M. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steriod, pregnane-3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J. Clin. Invest., 1964, 43: 2037–2047.; Bevan BR, Holton JB. Inhibition of bilirubin conjugation in rat liver slices by free fatty acids, with relevance to the problem of breast milk jaundice. Clin. Chim. Acta., 1972, 41: 101–107.; Gourley GR, Arend RA. β-Glucuronidase and hyperbilirubinemia in breast-fed and formulafed babies. Lancet, 1986, 1: 644–646.; Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, Maisels MJ, Lau J. An Evidence-Based Review of Important Issues Concerning Neo natal Hyperbilirubinemia. Pediatrics, 2004, 114: e130–e153.; Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics, 2009, 124: 1193–1198.; Горяйнова А.Н., Анцупова М.А., Захарова И.Н. Желтухи здорового новорожденного. Причины. Течение. Прогноз. Медицинский совет, 2017, 19.; Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, Jansen PL. Bilirubin UDPglucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem., 1994, 269: 17960–17964.; Arias IM, Gartner LM, Seifter S, Furman M. Prolonged Neonatal Unconjugated Hyperbilirubinemia Associated with Breast Feeding and a Steroid, Pregnane-3(Alpha), 20(Beta)-Diol, in Maternal Milk That Inhibits Glucuronide Formation in Vitro. J Clin Invest, 1964, 43: 2037–47.; Kumral A, Ozkan H, Duman N, Yesilirmak DC, Islekel H, Ozalp Y. Breast milk jaundice correlates with high levels of epidermal growth factor. Pediatr Res, 2009, 66: 218–21.; Maruo Y1, Nishizawa K, Sato H, Sawa H, Shimada M.Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphateglucuronosyltransferase gene. Pediatrics, 2000 Nov, 106(5): E59.; Maruo Y, Morioka Y, Fujito H, Nakahara S, Yanagi T, Matsui K, Mori A, Sato H, Tukey RH, Takeuchi Y. Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice. J Pediatr, 2014, 165(1): 36–41.; Ефимов М.С., Дегтярева А.В. Желтухи ново- рожденных. Неонатология. Национальное руководство. Краткое издание. Под ред. Н.Н. Володина. М.: ГЭОТАР-Медиа, 2016: 490-502.; Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin clearance. Pediatr. Res., 2016, 79: 378–386.; Gartner LM. Journal of Perinatology, 2001, 21: 25-29.; Bloomer JR, Barrett PV, Rodkey FL, et al. Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterology, 1971, 61: 479–487.; White GL Jr, Nelson JA, Pedersen DM, et al. Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. Clin Chem, 1981, 27: 1140–1142.; Дегтярева А.В., Дегтярев Д.Н. Cовременные принципы диагностики и лечения негемолитической гипербилирубинемии у доношенных и «поздних» недоношенных детей в раннем неонатальном периоде. Неонатология: новости, мнения, обучение, 2014, 3: 67-76.; Dewey KG, Nommsen-Rivers LA, Heinig MJ et al. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics, 2003, 112: 607-619.; Seagraves K, Brulte A, McNeely K, Pritham U. Supporting breastfeeding to reduce newborn readmissions for hyperbilirubinemia. Nurs Womens Health, 2013 Dec, 17(6): 498-507.; De Carvalho M, Klaus MH, Merkatz RB. Frequency of breast-feeding and serum bilirubin concentration. Am J Dis Child, 1982, 136: 737–8.; Yamauchi Y, Ymanouchi H. The relationship between rooming – in / notrooming – in and breast – feeding variables. Acta Pediatr Scand, 1990, 79: 1017–22.; Kuhr M, Paneth N. Feeding practices and early neonatal jaundice. J Pediatr Gastroenterol Nutr, 1982, 1: 485–8.; Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breastfed term newborns. Pediatrics, 1995, 96: 730–3.; Weisman LE, Merenstein GB, Digirol M, et al. The effect of early meconium evacuation on early – onset hyperbilirubinemia. Am J Dis Child, 1983, 137: 666–8.; Brodersen R, Herman LS. Intestinal absorption of unconjugated bilirubin: a possible contributing factor in neonatal jaundice. Lancet,1963, I: 1242.; American Academy of Pediatrics: Breastfeeding and the use of human milk. Pediatrics, 2012, 129: e827-841.; ABM clinical protocol #3: Hospital guidelines for the use of supplementary feedings in the healthy term breastfed neonate, revised 2009. Breastfeed Med, 2009, 4: 175–182.; ABM clinical protocol #22: guidelines for management of jaundice in the breastfeeding infant equal to or greater than 35 weeks’ gestation. Academy of Breastfeeding Medicine Protocol Committee. Breastfeed Med, 2010 Apr, 5(2): 87-93.; Protocol #10: Breastfeeding the Near Term Infant (35 to 37 Week Gestation). Academy of Breastfeeding Medicine. 2005. Breastfeeding Medicine, 2011, 6(3).; http://www.medela-russia.ru.; https://www.med-sovet.pro/jour/article/view/2288

الاتاحة: https://www.med-sovet.pro/jour/article/view/2288
https://doi.org/10.21518/2079-701X-2018-2-58-62

المؤلفون: V. B. Volkov, I. Ye. Borodaiev, K. P. Kirpichnikova, V. H. Shevchenko, B. S. Zaporozhchenko, P. T. Muraviov, Harhouri Makrem

المساهمون: Odesa National Medical University, № 0109U008575

المصدر: Patologìâ, Vol 17, Iss 3, Pp 351-355 (2020)
Патологія; № 3 (2020)
Pathologia; № 3 (2020)
Патология; № 3 (2020)

مصطلحات موضوعية: medicine.medical_specialty, Bilirubin, pancreatic cancer, Positive correlation, Gastroenterology, Mechanical Jaundice, Resection, chemistry.chemical_compound, Internal medicine, medicine, lcsh:Pathology, pancreas, resection, Surgical treatment, гіпербілірубінемія, больовий синдром, підшлункова залоза, рак підшлункової залози, резекція, hyperbilirubinhaemia, Pain syndrome, business.industry, Perioperative, Intensity (physics), chemistry, гипербилирубинемия, болевой синдром, поджелудочная железа, рак поджелудочной железы, резекция, pain syndrome, business, lcsh:RB1-214

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf802d36ae93adac29dcce0ee90f3c8
http://pat.zsmu.edu.ua/article/view/221820/223152